Search
Search Results
##search.searchResults.foundPlural##
-
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1617PDF: 898HTML: 1876Untitled: 195Untitled: 179 -
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6810PDF: 3644HTML: 753 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3912Suppl. Files: 1110PDF: 1065Html: 175 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3687PDF: 1437HTML: 182 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5142PDF: 1318HTML: 2744Cover letter: 192 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2189PDF: 1486HTML: 266 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4098PDF: 1585HTML: 948 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2236PDF: 871HTML: 2092 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1714PDF: 834HTML: 146 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2412PDF: 859HTML: 2457 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2577PDF: 861HTML: 17469Fig1 Caligaris: 171Fig.2 Caliga: 203 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2174PDF: 2002HTML: 173 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2120PDF: 1691HTML: 377 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1042PDF: 1154Suppl. Files: 569HTML: 87 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3145PDF: 1138HTML: 1484Untitled: 176Untitled: 165Untitled: 167 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2491PDF: 838HTML: 8820Efremov 1: 226Efremov 2: 189 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3546PDF: 1569HTML: 80 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3053PDF: 875HTML: 7163Kost Fig1: 182Kost Fig 2: 177Kost Fig3: 174Kost Fig 4: 190Kost Fig5: 184Kost fig 6: 173 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2651PDF: 1075HTML: 118 -
How I treat acute and persistent sickle cell pain
1919PDF: 1115HTML: 485 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2788PDF: 1116HTML: 11215 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3754PDF: 1482HTML: 485Figures . Eliassian: 222 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3546PDF: 2411HTML: 1461 -
IMMUNOLOGY OF TUBERCULOSIS
5279PDF: 2002HTML: 7319Untitled: 195 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3216PDF: 1430HTML: 5844Fig1-Ag-Pil: 226Ag-Pil Fig.2: 227 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3742PDF: 1561HTML: 8031Randi Fig: 181 -
SICKLE CELL ANAEMIA AND MALARIA
11423PDF: 6986HTML: 23853Figures Malaria and SCK: 210 -
-
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2579PDF: 798HTML: 5212 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2214PDF: 964HTML: 1897 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2290PDF: 1324HTML: 17079Bassan Fig.1: 143Bassan Fig.2: 153Bassan Fig.4: 142Fig.3: 184







